13 / 16
Infectious Diseases
and STD-AIDS
Infectious Diseases and STD-AIDS 2018
Journal of Transmitted Diseases and Immunity
ISSN 2471-8084
A p r i l 2 6 - 2 7 , 2 0 1 8
R o m e , I t a l y
Page 33
Background:
PMTCT program in Rwanda was initiated in 1999 with a piloting
phase in one Health Centre. Subsequently, PMTCT service delivery has been
expanded and now over 542 (96%) of public health facilities are covered.
Further, the country aims to maintain mother to child transmission as low as
2% by 2020. We report on trend analysis of national program data that was
carried for the last 10 years.
Methods:
we reviewed National PMTCT guidelines and analysed national data
on HIV testing among pregnant women, their partners and children in national
PMTCT program from January 2006 to December 2016.
Results:
In Rwanda, PMTCT protocol changed over time based on new
evidences, it started with single dose Niverapine during labour then AZT for the
pregnant mother and Nevirapine for exposed children (option A) to tri-therapy
from14 weeks of pregnancy up to the weaning period (option B), since 2012 the
country is implementing option B+ requiring that the pregnant woman receive
life-long antiretroviral therapy. Pregnant women tested for HIV increased from
88 to 99% and their prevalence decreased from 5.5% to 0.7% between 2006
and 2016. Women who accessed antiretroviral therapy increased from 80%
in 2006 to 98.5% in 2016, this resulted into a decrease of HIV transmission
among infants aged 18 months from 9.3% to 1.5%. Of male partners tested
in PMTCT, the percentage increased from 30% in 2006 to 84.9% in 2016, their
prevalence decreased from 5.4 to 0.9% in the same period.
Conclusions & Recommendations:
PMTCT program have been scaled up
successfully in Rwanda, there is an increase in HIV testing and a decline in
HIV prevalence among pregnant women, partners and their children, indicating
successful HIV prevention efforts. The success of PMTCT program in Rwanda
result to political commitment, involvement of stakeholders and the whole
community.
Biography
Karangwa Chaste has completed his masters in Epidemiology
from National University of Rwanda. He is In Charge of PMTCT
department in Rwanda Biomedical Centre/HIV Division. He has
published more than three papers in reputed conferences.
kchaste92@gmail.comKey achievements in PMTCT program: Rwanda 2006-2016
Karangwa Chaste, Jean De Dieu Ntwali, Eric Remera and
Placidie Mugwaneza
Rwanda Biomedical Center, Rwanda
Karangwa Chaste et al., J Transm Dis Immun 2018 Volume 2
DOI: 10.21767/2573-0320-C1-002